Hindustan Foods Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 9, 2025, 11:21 am

Quick Insight

Hindustan Foods Ltd, currently trading at ₹541 with a market capitalization of ₹6,355 crore, exhibits a high Price-to-Earnings (P/E) ratio of 58.0, indicating investor optimism but also a potential overvaluation relative to earnings. The company’s Return on Equity (ROE) and Return on Capital Employed (ROCE) stand at 14.3% and 14.4%, respectively, suggesting efficient capital utilization. However, an Operating Profit Margin (OPM) of 8% raises concerns about profitability, particularly given the ₹896 crore in borrowings against ₹868 crore in reserves, leading to an Interest Coverage Ratio (ICR) of 4.04x. With promoter holding at 63.82% and a diverse shareholder base, the firm's stability seems bolstered, yet the elevated Price-to-Book Value (P/BV) of 8.36x may warrant caution. Investors should weigh these factors carefully, as the current valuation may not reflect sustainable growth potential in the competitive food processing sector.

Competitors of Hindustan Foods Ltd

All Competitor Stocks of Hindustan Foods Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:59 am

Below is a detailed analysis of the quarterly data for Hindustan Foods Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 933.00 Cr.. The value appears strong and on an upward trend. It has increased from 880.00 Cr. (Dec 2024) to 933.00 Cr., marking an increase of 53.00 Cr..
• For Expenses, as of Mar 2025, the value is 856.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 806.00 Cr. (Dec 2024) to 856.00 Cr., marking an increase of 50.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Dec 2024) to 77.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Mar 2025, the value is 8.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 8.00%.
• For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Dec 2024) to 3.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 20.00 Cr..
• For Depreciation, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 20.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Dec 2024) to 41.00 Cr., marking an increase of 2.00 Cr..
• For Tax %, as of Mar 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Dec 2024) to 24.00%, marking a decrease of 3.00%.
• For Net Profit, as of Mar 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Dec 2024) to 31.00 Cr., marking an increase of 2.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.62. The value appears strong and on an upward trend. It has increased from 2.44 (Dec 2024) to 2.62, marking an increase of 0.18.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 10:51 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:35 pm

Below is a detailed analysis of the balance sheet data for Hindustan Foods Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 868.00 Cr.. The value appears strong and on an upward trend. It has increased from 622.00 Cr. (Mar 2024) to 868.00 Cr., marking an increase of 246.00 Cr..
• For Borrowings, as of Mar 2025, the value is 896.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 731.00 Cr. (Mar 2024) to 896.00 Cr., marking an increase of 165.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 704.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 549.00 Cr. (Mar 2024) to 704.00 Cr., marking an increase of 155.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,491.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,924.00 Cr. (Mar 2024) to 2,491.00 Cr., marking an increase of 567.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,012.00 Cr.. The value appears strong and on an upward trend. It has increased from 908.00 Cr. (Mar 2024) to 1,012.00 Cr., marking an increase of 104.00 Cr..
• For CWIP, as of Mar 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 119.00 Cr., marking an increase of 110.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,359.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,007.00 Cr. (Mar 2024) to 1,359.00 Cr., marking an increase of 352.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,491.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,924.00 Cr. (Mar 2024) to 2,491.00 Cr., marking an increase of 567.00 Cr..

However, the Borrowings (896.00 Cr.) are higher than the Reserves (868.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Hindustan Foods Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 8.23. This value is within the healthy range. It has increased from 6.31 (Mar 23) to 8.23, marking an increase of 1.92.
• For Diluted EPS (Rs.), as of Mar 24, the value is 8.23. This value is within the healthy range. It has increased from 6.31 (Mar 23) to 8.23, marking an increase of 1.92.
• For Cash EPS (Rs.), as of Mar 24, the value is 12.90. This value is within the healthy range. It has increased from 9.63 (Mar 23) to 12.90, marking an increase of 3.27.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.32. It has increased from 33.18 (Mar 23) to 56.32, marking an increase of 23.14.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.32. It has increased from 33.18 (Mar 23) to 56.32, marking an increase of 23.14.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 240.43. It has increased from 230.45 (Mar 23) to 240.43, marking an increase of 9.98.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 19.98. This value is within the healthy range. It has increased from 15.76 (Mar 23) to 19.98, marking an increase of 4.22.
• For PBIT / Share (Rs.), as of Mar 24, the value is 15.20. This value is within the healthy range. It has increased from 12.45 (Mar 23) to 15.20, marking an increase of 2.75.
• For PBT / Share (Rs.), as of Mar 24, the value is 10.25. This value is within the healthy range. It has increased from 9.27 (Mar 23) to 10.25, marking an increase of 0.98.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 8.12. This value is within the healthy range. It has increased from 6.31 (Mar 23) to 8.12, marking an increase of 1.81.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 8.12. This value is within the healthy range. It has increased from 6.31 (Mar 23) to 8.12, marking an increase of 1.81.
• For PBDIT Margin (%), as of Mar 24, the value is 8.30. This value is below the healthy minimum of 10. It has increased from 6.84 (Mar 23) to 8.30, marking an increase of 1.46.
• For PBIT Margin (%), as of Mar 24, the value is 6.31. This value is below the healthy minimum of 10. It has increased from 5.40 (Mar 23) to 6.31, marking an increase of 0.91.
• For PBT Margin (%), as of Mar 24, the value is 4.26. This value is below the healthy minimum of 10. It has increased from 4.02 (Mar 23) to 4.26, marking an increase of 0.24.
• For Net Profit Margin (%), as of Mar 24, the value is 3.37. This value is below the healthy minimum of 5. It has increased from 2.73 (Mar 23) to 3.37, marking an increase of 0.64.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.37. This value is below the healthy minimum of 8. It has increased from 2.73 (Mar 23) to 3.37, marking an increase of 0.64.
• For Return on Networth / Equity (%), as of Mar 24, the value is 14.41. This value is below the healthy minimum of 15. It has decreased from 19.01 (Mar 23) to 14.41, marking a decrease of 4.60.
• For Return on Capital Employeed (%), as of Mar 24, the value is 14.08. This value is within the healthy range. It has decreased from 16.89 (Mar 23) to 14.08, marking a decrease of 2.81.
• For Return On Assets (%), as of Mar 24, the value is 4.83. This value is below the healthy minimum of 5. It has decreased from 5.32 (Mar 23) to 4.83, marking a decrease of 0.49.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.76. This value is within the healthy range. It has decreased from 1.02 (Mar 23) to 0.76, marking a decrease of 0.26.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.06. This value exceeds the healthy maximum of 1. It has decreased from 1.31 (Mar 23) to 1.06, marking a decrease of 0.25.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.69. It has decreased from 2.31 (Mar 23) to 1.69, marking a decrease of 0.62.
• For Current Ratio (X), as of Mar 24, the value is 1.26. This value is below the healthy minimum of 1.5. It has increased from 1.18 (Mar 23) to 1.26, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 1. It has increased from 0.52 (Mar 23) to 0.54, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.64. This value is within the healthy range. It has decreased from 8.02 (Mar 23) to 5.64, marking a decrease of 2.38.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.04. This value is within the healthy range. It has decreased from 4.96 (Mar 23) to 4.04, marking a decrease of 0.92.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.64. This value is below the healthy minimum of 3. It has decreased from 2.99 (Mar 23) to 2.64, marking a decrease of 0.35.
• For Enterprise Value (Cr.), as of Mar 24, the value is 6,030.76. It has decreased from 6,130.98 (Mar 23) to 6,030.76, marking a decrease of 100.22.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.19. This value is within the healthy range. It has decreased from 2.36 (Mar 23) to 2.19, marking a decrease of 0.17.
• For EV / EBITDA (X), as of Mar 24, the value is 26.35. This value exceeds the healthy maximum of 15. It has decreased from 34.50 (Mar 23) to 26.35, marking a decrease of 8.15.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.96. This value is within the healthy range. It has decreased from 2.19 (Mar 23) to 1.96, marking a decrease of 0.23.
• For Price / BV (X), as of Mar 24, the value is 8.36. This value exceeds the healthy maximum of 3. It has decreased from 15.21 (Mar 23) to 8.36, marking a decrease of 6.85.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.96. This value is within the healthy range. It has decreased from 2.19 (Mar 23) to 1.96, marking a decrease of 0.23.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness